Literature DB >> 17485628

The natural history of pityriasis rosea in black American children: how correct is the "classic" description?

Ahdi Amer1, Howard Fischer, Xiaoming Li.   

Abstract

OBJECTIVES: To delineate the natural history of pityriasis rosea in black children and to compare our findings with those of the American, European, and African literature on pityriasis rosea. Textbook and journal article descriptions of pityriasis rosea usually offer information about the presentation and clinical course of this condition in white patients.
DESIGN: Prospective observational study.
SETTING: The general pediatric clinic, adolescent clinic, and emergency department of Children's Hospital of Michigan, Detroit, from June 2003 through May 2005. PATIENTS: We followed up 50 black children with pityriasis rosea from the time of diagnosis through follow-up visits at 1, 2, and 4 weeks. Detailed observations were made and digital photographs taken at each visit. MAIN OUTCOME MEASURES: Duration of illness and pigmentary sequelae.
RESULTS: Similarities with the medical literature were found regarding season of onset and prevalence of pruritus and of a herald patch. Our patients had more frequent facial involvement (30%) and more scalp lesions (8%) than usually described in white populations. One third had papular lesions. The disease resolved in nearly one half of patients within 2 weeks. Residual hyperpigmentation was seen in 48% of patients. Hypopigmentation developed in 29% of patients with purely papular or papulovesicular lesions.
CONCLUSIONS: Pityriasis rosea in black children differs in several ways from textbook descriptions. Physicians may use this information to better counsel patients about the course and potential sequelae of this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485628     DOI: 10.1001/archpedi.161.5.503

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  11 in total

1.  Unilateral pityriasis rosea in a child.

Authors:  Vijay Zawar
Journal:  J Dermatol Case Rep       Date:  2010-12-31

2.  Follicular pityriasis rosea. A case report and a new classification of clinical variants of the disease.

Authors:  Vijay Zawar; Antonio Chuh
Journal:  J Dermatol Case Rep       Date:  2012-06-30

3.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

4.  Atypical Pityriasis rosea in a black child: a case report.

Authors:  Sergio Vano-Galvan; Dong-Lai Ma; Alejandro Lopez-Neyra; Bibiana Perez; Ernesto Muñoz-Zato; Pedro Jaén
Journal:  Cases J       Date:  2009-04-29

5.  Childhood Pityriasis rosea inversa without Herald Patch Mimicking Cutaneous Mastocytosis.

Authors:  Aylin Türel Ermertcan; Aykan Ozgüven; Pelin Ertan; Cemal Bilaç; Peyker Temiz
Journal:  Iran J Pediatr       Date:  2010-06       Impact factor: 0.364

6.  Pityriasis amiantacea-like eruptions in scalp: a novel manifestation of pityriasis rosea in a child.

Authors:  Vijay Zawar
Journal:  Int J Trichology       Date:  2010-07

7.  Oligo-lesional eruptions rapidly following a herald plaque: abortive pityriasis rosea.

Authors:  Vijay Zawar
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

8.  Acral pityriasis rosea in an infant with palmoplantar lesions: A novel manifestation.

Authors:  Vijay Zawar
Journal:  Indian Dermatol Online J       Date:  2010-07

Review 9.  Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.

Authors:  Khushbu Mahajan; Vineet Relhan; Aditi Kochhar Relhan; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

10.  Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus.

Authors:  Anna Neneman; Dominik Mikiel; Zygmunt Adamski; Monika Bowszyc-Dmochowska
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.